| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f5a8e9a431f105dbe1c095fde0b48ee |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2021-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d48af536f342a46ed4aef4c5aa5a8b89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88c862de1ecac543f7a033b89d00a203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e71326f771f63b3497d267148b6817e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48a17b1010f38b22a4a08da4fc22e0d4 |
| publicationDate |
2022-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022015887-A1 |
| titleOfInvention |
Combination drug formulations including rotigotine and an acetylcholinesterase inhibitor for the treatment of neurodegenerative diseases |
| abstract |
This disclosure relates to the pharmacological treatment of apathy and loss of executive function in treatment of neurodegenerative diseases by administration of a combination drug formulation including rotigotine and an acetylcholinesterase inhibitor. |
| priorityDate |
2020-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |